Released Mar 19, 2018, after the close
10-Q filed Mar 19, 2018, 47 days after period end · 0001654954-18-002767
Q1 2018 · 10-Q
Revenue$3.73M$3.73M no prior Q1 2017 on fileno prior Q4 2017 on file
Net Income-$2.66M-$2.66M N/M vs Q1 2017N/M vs Q4 2017
EPS Diluted-$0.12-$0.12 N/M vs Q1 2017no prior Q4 2017 on file
Gross Profit$1,181,526+14.5%
Operating Income-$2,472,314N/M
Operating Cash Flow$1,416,930+664.3%
Free Cash Flowderived$1,365,815N/M
Margins · derived
Gross margin31.7%
Operating margin-66.3%
Net margin-71.5%
What the release said
The release
Same quarter
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Revenue | $3.73M | — | — | — |
| Net Income | -$2.66M | -$382.14K | $350.01K | $288.39K |
| EPS Diluted | -$0.12 | -$0.02 | $0.02 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR